15 |
Drug-Eluting Stents, Late Loss, and Restenosis DES to Prevent MIs |
Richard E. Kuntz |
Sep. 29. 05 |
14 |
Preventative Effects of Rosiglitazone on Restenosis after Coronary Stent Implantation |
Donghoon Choi |
Sep. 23. 05 |
13 |
DES for Complex Patients Subsets |
Alexandre Abizaid |
Jul. 15. 05 |
12 |
Drug-eluting Stents,Late Loss,and Restenosis DES to Prevents MIs |
Richard E. Kuntz |
Jul. 01. 05 |
11 |
Late Loss Remains the Best Single Indicator of DES Performance |
Richard E. Kuntz |
May. 27. 05 |
10 |
Updates from... the FIM Experience: Are the Results Durable?(in Coronary De Nove and ISR) |
Gary S. Mintz |
Mar. 04. 05 |
9 |
PPAR-r Agonist and In-stent Restenosis |
Yangsoo Jang |
Jan. 14. 05 |
8 |
Five-Year Follow-UP after Treatment of Diffuse In-Stent Restenosis with Rotational Atherectomy Followed by Radiation Therapy with a 188Re-MAG3-Filled Balloon |
Seong-Wook Park |
Sep. 10. 04 |
7 |
Should We Expect "Late Catch-up"(Late Restenosis) After DES Treatment-Is the Genie Already out of the Bottle? You Have Simply Postponed the Inevitable |
Renu Virmani |
Jun. 18. 04 |
6 |
A Pro-healing Approach to Stent Thrombo-resistance and Restenosis Prevention: Endothelial Progenitor Cell Capture |
Michael Kutryk |
May. 13. 04 |